Emami (531162) Stock Overview
Manufactures and markets personal and healthcare products in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 6/6 |
Rewards
Risk Analysis
No risks detected for 531162 from our risk checks.
531162 Community Fair Values
Create NarrativeSee what 8 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Emami Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹368.30 |
| 52 Week High | ₹605.25 |
| 52 Week Low | ₹361.25 |
| Beta | 0.14 |
| 1 Month Change | -8.11% |
| 3 Month Change | -10.84% |
| 1 Year Change | -36.51% |
| 3 Year Change | -28.99% |
| 5 Year Change | -37.27% |
| Change since IPO | 15,628.13% |
Recent News & Updates
Recent updates
531162: Upcoming May Results Will Support Bullish Long-Term Outlook
Analysts have trimmed their fair value estimate for Emami to ₹671 from about ₹745, citing updated expectations around revenue growth, profit margins and a lower projected future P/E multiple. What’s in the News for Emami Emami has scheduled a board meeting on May 21, 2026, at 12:00 Indian Standard Time to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.
531162: May Board Meeting And Leadership Review Will Support Bullish Outlook
Analysts have trimmed their price target on Emami to ₹545 from about ₹637, citing refreshed assumptions around slightly higher discount rates, more moderate revenue growth, softer profit margins, and a lower future P/E multiple. What’s in the News for Emami Emami has scheduled a Board meeting on May 21, 2026, at 12:00 Indian Standard Time to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.
531162: Trimmed Fair Value And Rich Future P/E Will Shape Measured Outlook
Analysts have trimmed their price target on Emami from ₹425.00 to ₹415.00, reflecting updates to their models that now factor in different assumptions for the discount rate, revenue growth, profit margin and future P/E. What's in the News A board meeting is scheduled for May 21, 2026, at 12:00 Indian Standard Time to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.531162: Upcoming May Results And Board Decisions Will Support Bullish Outlook
Analysts have trimmed their fair value estimate for Emami from ₹800 to about ₹745, citing updated assumptions that include slightly higher revenue growth expectations, along with a lower projected profit margin and a reduced future P/E multiple. What's in the News Board meeting scheduled for May 21, 2026, at 12:00 Indian Standard Time to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026 (company filing).531162: Upcoming Results And Higher Board Meeting Focus Will Support Bullish Outlook
Analysts have raised their price target on Emami from ₹775.37 to ₹800.00, reflecting updated assumptions around discount rates, revenue growth, profit margins, and future P/E multiples. What's in the News Emami has scheduled a board meeting for May 21, 2026.531162: Interim Dividend Will Be Insufficient To Offset Rich Future P/E
Analysts have cut their price target on Emami from about ₹453 to ₹425, reflecting updated assumptions for slightly higher revenue growth, a marginally higher discount rate, and a lower future P/E multiple. What's in the News Board meeting scheduled for May 21, 2026, to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026 (company filing).531162: Interim Dividend And Revised Assumptions Will Support A Balanced Outlook
Analysts have trimmed their price target on Emami from ₹510 to about ₹453, pointing to updated assumptions around a lower future P/E multiple, an adjusted discount rate, and revised expectations for revenue growth and profit margins. What's in the News The board of directors declared a 2nd interim dividend of ₹6 per equity share of face value ₹1 each, described as 600% on 436,500,000 equity shares for the financial year 2025-26 (Key Developments).531162: Second Interim Dividend Will Support Bullish Long Term Outlook
Analysts have trimmed their price target on Emami by about ₹31 to reflect updated assumptions around fair value, discount rate, revenue growth, profit margin, and future P/E expectations. What's in the News The board approved a second interim dividend of ₹6 per equity share of ₹1 each, equal to 600% on 436,500,000 equity shares for FY 2025-26, with the record date set for 10 February 2026 and payment scheduled on or before 6 March 2026 (Key Developments).531162: February Dividend And Board Review Will Support Bullish Outlook
Analysts have trimmed their fair value estimate for Emami to ₹637 from ₹651, citing slightly adjusted assumptions on discount rate, revenue growth, profit margin and future P/E that point to a marginally more conservative outlook on the stock's valuation. What's in the News A board meeting on 4 February 2026 to review unaudited standalone and consolidated financial results for the quarter ended 31 December 2025 and to consider a 2nd interim dividend for FY 2025-26 (company filing).531162: Interim Dividend And Stable Assumptions Will Support A Balanced Outlook
Analysts have maintained their fair value estimate for Emami at ₹510. They have made only minor adjustments to assumptions such as discount rate, revenue growth, profit margin and future P/E, which feed into the updated price target rationale.531162: Board Review And Interim Dividend Will Shape A Balanced Outlook
Analysts have trimmed their price target for Emami from ₹540.54 to ₹510.00, citing refreshed assumptions that include slight adjustments to revenue growth, profit margins and the future P/E multiple under a marginally lower discount rate. What's in the News Emami has scheduled a board meeting on Feb 04, 2026 to review unaudited standalone and consolidated financial results for the quarter ended 31 December, 2025 (Key Developments).531162: February Board Meeting And Dividend Decision Will Reinforce Bullish Outlook
Analysts have trimmed their price target for Emami slightly to ₹651 from about ₹653. The adjustment reflects small tweaks to their fair value, discount rate, revenue growth and profit margin assumptions, alongside a marginally lower expected future P/E multiple.531162: February Dividend Decision Will Support Bullish Long-Term View
Analysts have made only a minor adjustment to their price view on Emami, with the updated fair value at ₹653.25. A slightly lower discount rate, along with revised assumptions for revenue growth, profit margin, and future P/E, serve to fine tune rather than overhaul the prior framework.531162: Upcoming Dividend Decision Will Support Bullish Long Term Outlook
Analysts have trimmed their price target on Emami from ₹883 to ₹807. This reflects slightly lower margin and valuation expectations that more than offset modestly stronger projected revenue growth and a reduced discount rate.531162: Interim Dividend Decision At November Meeting Will Support Bullish Outlook
Analysts have nudged their price target on Emami slightly higher to align with a fair value of ₹653.25. This reflects marginally lower perceived risk and a steady outlook on growth, margins, and future valuation multiples.531162: Board Will Consider Interim Dividend At November 10 Results Meeting
Analysts have revised their price target for Emami down from ₹697.96 to ₹653.25. They cite updated assessments of the company's growth prospects and valuation metrics as reasons for the change.531162: Board To Weigh Interim Dividend At November 10 Meeting
Analysts have slightly revised their price target for Emami downward from ₹706.24 to ₹697.96. This change reflects minor adjustments in growth and profitability expectations.
Relaunching Fair And Handsome And Capitalizing On Dermicool Innovations Will Propel Earnings Growth
Strategic relaunches and product innovations aim to boost revenue, particularly in Fair and Handsome, Kesh King, Dermicool, and BoroPlus Soft segments.Shareholder Returns
| 531162 | IN Personal Products | IN Market | |
|---|---|---|---|
| 7D | 1.2% | 0.8% | -0.3% |
| 1Y | -36.5% | -21.8% | -3.0% |
Return vs Industry: 531162 underperformed the Indian Personal Products industry which returned -22.1% over the past year.
Return vs Market: 531162 underperformed the Indian Market which returned -3.7% over the past year.
Price Volatility
| 531162 volatility | |
|---|---|
| 531162 Average Weekly Movement | 3.9% |
| Personal Products Industry Average Movement | 5.0% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in IN Market | 8.9% |
| 10% least volatile stocks in IN Market | 3.4% |
Stable Share Price: 531162 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 531162's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1974 | 3,097 | Harsha Agarwal | www.emamiltd.in |
Emami Limited, together with its subsidiaries, manufactures and markets personal and healthcare products in India and internationally. The company offers antiseptic creams, body lotions, soaps, aloe vera gels, petroleum jellies, prickly heat powders, and all-season creams under the BoroPlus brand; cool oils and talcs under the Navratna brand; ayurvedic products for pain management, immunity, digestive health, and bone and joint health, as well as pain balms, healthcare, generics, and ethical products under the Zandu brand; ayurvedic medicinal oils, shampoos, and conditioners under the Kesh King brand; and brightening creams, brightening face washes, and oil clear face washes for men under the Smart And Handsome brand. It also provides pain balms under the Emami Mentho Plus brand; light hair oils under the Emami 7 Oils in One brand; prickly heat powders and sprays, soaps, and shower gels under the Dermicool brand; German skincare products under the Creme 21 brand; deodorants, eau de toilettes, shampoos, face and body washes, and shower gels under the HE brand; body sprays and perfumes, as well as face, hair, body, beard, and shaving products under The Man Company brand; and face serums, oil shots, powder face washes, and hair and pure oils under the Brillare brand.
Emami Limited Fundamentals Summary
| 531162 fundamental statistics | |
|---|---|
| Market cap | ₹160.76b |
| Earnings (TTM) | ₹7.48b |
| Revenue (TTM) | ₹39.15b |
Is 531162 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 531162 income statement (TTM) | |
|---|---|
| Revenue | ₹39.15b |
| Cost of Revenue | ₹12.56b |
| Gross Profit | ₹26.59b |
| Other Expenses | ₹19.11b |
| Earnings | ₹7.48b |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
Nov 13, 2026
| Earnings per share (EPS) | 17.14 |
| Gross Margin | 67.93% |
| Net Profit Margin | 19.12% |
| Debt/Equity Ratio | 5.5% |
How did 531162 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/18 11:54 |
| End of Day Share Price | 2026/09/18 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Emami Limited is covered by 48 analysts. 21 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Parin Tanna | 360 ONE Capital Market Private Limited |
| Ajay Thakur | Anand Rathi Shares and Stock Brokers Limited |
| null null | Anand Rathi Shares and Stock Brokers Limited |